Gut barrier and gut inflammatory states in acute pancreatitis

Archives of Hellenic Medicine

Volumn 20, Issue SUPPL. A, 2003, Pages 61-67

  Andersson, R ^a   Andersson, E ^a   Axelsson, J ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute pancreatitis; Gut barrier; Inflammation

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ACUTE PHASE RESPONSE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL TRANSLOCATION; CONFERENCE PAPER; HUMAN; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; MICROCIRCULATION; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

EID: 0042694378     PISSN: 11053992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. APPELROS S, BORGSTROM A. Incidence, aetiology, and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999, 86:465-470
2. MCKAY CJ, EVANS S, SINCLAIR M, CARTER CR, IMRIE CW. High early mortality rate from acute pancreatitis in Scotland 1984-1995. Br J Surg 1999, 86:1382-1385
3. ASHLEY SW, PEREZ A, PIERCE EA, BROOKS DC, MOORE FD JR, WHANG EE ET AL. Necrotizing pancreatitis: contemporary analysis of 99 consecutive cases. Ann Surg 2001, 234:572-579
4. BEGER HG, RAU B, MAYER J, PRALLE U. Natural course of acute pancreatitis. World J Surg 1997, 21:130-135
5. HALONEN KI, PETTILA V, LEPPANIEMI AK, KEMPPAINEN EA, PUOLAKKAINEN PA, HAAPPIAINEN RK. Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002, 30:1274-1279
6. KNAUS WA, DRAPER EA, WAGNER DP, ZIMMERMAN JE. Prognosis in acute organ-system failure. Ann Surg 1985, 202:685-693
7. TRAN DD, CUESTA MA, VAN LEEUWEN PA, NAUTA JI, WESDORP RE. Risk factors for multiple organ-system failure and death in critically injured patients. Surgery 1993, 114:21-30
8. de BEAUX AC, GOLDIE AS, ROSS JA, CARTER DC, FEARON KCH. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996, 83:349-353
9. MCKAY CJ, GALLAGHER G, BROOKS C, IMRIE CW, BAXTER JM. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996, 83:919-923
10. LUNDBERG AH, GRANGER N, RUSSELL J, SABEK O, HENRY J, GABER L ET AL. Quantitative measurement of P-and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg 2000, 231:213-222
11. BLUM T, MAISONNEUVE P, LOWENFELS AB, LANKISCH BG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 2001, 1:237-241
12. LUMSDEN A, BRADLEY III EL. Secondary pancreatic infections. Surg Gynecol Obstet 1990, 81:180-191
13. BEGER HG, BITTNER R, BLOCH S, BUCHLER M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91:433-441
14. BRADLEY EL, ALLER K. A prospective longitudinal study of obstruction vs surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991, 161:19-21
15. OGAWA M. Acute pancreatitis and cytokines: "second attack" by septic complications lead to organ failure. Pancreas 1998, 3:312-315
16. FOITZIK T. The enteral factor in pancreatic infection. Pancreatology 2001, 1:217-223
17. GORIS RJA. Pathophysiology in shock and trauma. Eur J Surg 2000, 166:100-111
18. MARSHALL JC, CHRISTOU NV, MEAKINS JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993, 218:111-119
19. ANDERSSON R, SUN ZW, WANG XD, DENG XM, SOLTESZV, IHSE I. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. Pancreas 1998, 17:107-109
20. WANG XD, ANDERSSON R, SOLTESZ V, LEVEAU P, IHSE I. Gut origin sepsis, macrophage function and oxygen extraction in acute pancreatitis in the rat. World J Surg 1996, 20:299-308
21. WANG XD, ANDERSSON R. Intestinal brush-border membrane function. Scand J Gastroenterol 1994, 29:289-299
22. ANDERSSON R, WANG XD. Gut barrier dysfunction in experimental acute pancreatitis. Ann Acad Med Singapore 1999, 28:141-146
23. WERNER J, Z'GRAGEN K, FERNANDEZ-DEL CASTILLO C, LEWANDROWSKI KV, COMPTON CC, WARSHAW AL. Specific therapy for local and systemic complication of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg 1999, 226:834-842
24. AMMORI BJ, LEEDER BC, KING RF, BARCLAY GR, MARTIN IG, LARVIN M ET AL. Early increase in intestinal permeability in patients with severe acute pancreatitis with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999, 3:252-262
25. JUVONEN PO, ALHAVA EM, TAKALA JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000, 35:1314-1318
26. WANG XD, ANDERSSON R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. Eur J Surg 1995, 161:703-713
27. MAcFADDEN DW. Organ failure and multiple organ system failure in pancreatitis. Pancreas 1991, 6:S37-S43
28. WANG XD, WANG Q, ANDERSSON R, IHSE I. Alterations in intestinal function in acute pancreatitis in an experimental model. Br J Surg 1996, 83:1537-1542
29. LEVEAU P, WANG XD, SOLTESZ V, IHSE I, ANDERSSON R. Alterations in intestinal motility and microflora in experimental acute pancreatitis. Int J Pancreatol 1996, 20:119-125
30. ALGUL H, TANDO Y, SCHNEIDER G, WEIDENBACH H, ADLER G, SCHMID RM. Acute experimental pancreatitis in NF-kB/Rel activation. Pancreatology 2002, 2:503-509
31. ETHRIDGE RT, HASHIMOTO K, CHUNG DH, EHLERS RA, RAJARAJAM S, EVERS BM. Selective inhibition of NF-kB attenuates the severity of cerulein. J Am Coll Surg 2002, 195:497-505
32. SATOH A, SHIMOSEGAWA T, FUJIITA M, KIMURA K, MASAMUNE A, KOIZUMI M ET AL. Inhibition of nuclear factor-kB improves the survival of rats with taurocholate pancreatitis. Gut 1999, 44:253-258
33. NORMAN J. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion 1999, 60(Suppl 1):57-60
34. DIB M, ZHAO X, WANG XD, ANDERSSON R. The role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br J Surg 2002, 89:172-178
35. NORMAN J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998, 175:76-83
36. OSMAN MO, JENSEN SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins-new trends for treatment? Dig Surg 1999, 16:347-362
37. MENGER MD, PLUSCZYK T, VOLLMAR B. Microcirculatory derangements in acute pancreatitis. J Hepatobil Pancr Surg 2001, 8:187-194
38. WANG XD, SUN ZW, BORJESSON A, ANDERSSON R. Inhibition of platelet-activating factor, intracellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. Br J Surg 1999, 6:411-416
39. BONHAM MJ, ABU-ZIDAN FM, SIMOVIC MO, SLUIS KB, WILKINSON A, WINTERBOURN CC ET AL. Early ascorbic acid depletion is related to the severity of acute pancreatitis. Br J Surg 1999, 86:1296-1301
40. SCHULTZ HU, NIEDERAU C, KLONOWSKI-STUMPE H, HALLANGK W, LUTHEN R, LIPPERT H. Oxidative stress in acute pancreatitis. Hepatogastroenterology 1999, 46:2736-2750
41. RAU B, POCH B, GANSAUGE F, BAUER A, NUSSLER AK, NEVALAINEN T ET AL. Pathophysiologic role of oxygen-free radicals in acute pancreatitis: initiating event of mediator or tissue damage? Ann Surg 2000, 231:352-360
42. WANG XD, DENG XM, HARALDSEN P, ANDERSSON R, IHSE I. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. Scand J Gastroenterol 1995, 30:1129-1136
43. ISENMANN R, RAU B, BEGER HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999, 86:1020-1024
44. GLOOR B, MULLER CA, WORNI M, MARTIGNONI ME, UHL W, BUCHLER MW. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001, 88:975-979
45. GOLUB R, SIDDIQI F, POHL D. Role of antibiotics in acute pancreatitis: meta-analysis. J Gastrointest Surg 1998, 2:496-503
46. BASSI C, MANGIANTE G, FALCONI M, SALVI R, FRIGERIO I, PEDERZOLI P. Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobil Pancr Surg 2001, 8:211-215
47. POWELL JI, MILES R, SIRIWARDENA AK. Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998, 85:582-587
48. GLOOR B, MULLER CA, WORNI M, STAHEL PF, REDAELLI C, UHL W ET AL. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001, 136:592-596
49. ISENMANN R, SCHWARZ M, RAU B, TRAUTMANN M, SCHOBER W, BEGER HG. Characteristics of infection with candida species in patients with necrotizing pancreatitis. World J Surg 2002, 25:372-376
50. LUITEN EJ, HOP WCJ, LANGE JF, BRUINING HA. Controlled clinical trial of selective decontamination for the treatment for severe acute pancreatitis. Ann Surg 1995, 222:57-65
51. MANGIANTE G, COLUCCI G, CANEPARI P, BASSI C, NICOLI N, CASARI L ET AL. lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg 2001, 18:47-50
52. OLAH A, BELAGYI T, ISSEKUTZ A, GAMAL ME, BENGMARK S. Randomised clinical trial of specific lactobacillus and fiber supplement to early nutrition in patients with acute pancreatitis. Br J Surg 2002, 89:1103-1107
53. ECKERWALL G, ANDERSSON R. Early enteral nutrition in severe acute pancreatitis-a way of providing nutrients, gut barrier protection, immunomodulation or all of them? Scand J Gastroenterol 2001, 36:449-458
54. OLAH A, PARDAVI G, BELAGYI T, NAGY A, ISSEKUTZ A, MOHAMED GE. Early nasojejunal feeding in acute pancreatitis is associated with low complication rate. Nutrition 2002, 18:259-262
55. KALFARENTZOS F, KEHAGIAS N, MEAD K, KOKKINIS K, GOGOS CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomised prospective trial. Br J Surg 1997, 84:665-669
56. WINDSOR AC, KANWAR S, LI AG, BARNES E, GUTHRIE JA, SPARK JI ET AL. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998, 42:431-435
57. HEYLAND DK, NOVAK F, DROVER JW, JAYN M, SU X, SUCHNER U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001, 286:944-953
58. HARALDSEN P, SUN ZW, BORJESSON A, OLANDERS K, LASSON A, ANDERSSON R. Multimodal management-of value in fulminant acute pancreatitis? Pancreatology, 2003 (In press)